Previous (2016) Conference Program

Keynote Session Technical Sessions Special Session
  • Keynote Session

    IPJ-K
    June 30th[Thu]13:30-15:00Bilingual (English/Japanese)
    for Details
    The Key to Growth for Japan's Pharmaceutical Industry

    Be Passionate Challengers -Ono Pharmaceutical's Drug Discovery Innovation-

    相良 暁

    Gyo Sagara
    President,
    Representative Director, and Chief Executive Officer,
    Ono Pharmaceutical Co., Ltd.

    Supporting Innovative Drug Discovery with Global Development Environment Changes in Mind

    森 和彦

    Kazuhiko Mori
    Councilor for Pharmaceutical Affairs,
    Minister's Secretariat,
    Ministry of Health, Labour and Welfare

  • Technical Sessions

    June
    29

    [Wed]
    15:00
    |
    18:00
    IPJ-1

    Japanese Only

    for Details
    IPJ-6

    Japanese Only

    for Details

    Latest Trends in PIC/S GMP/GDP -Toward Meeting Quality Assurance Requirements-


    Hiroyuki Kawakita
    Principal Inspector,
    Office of Manufacturing / Quality and Compliance,
    Pharmaceuticals and Medical Devices Agency


    Osamu Takahashi
    cefic APIC Certified Auditor/
    Senior Consultant,
    GMP Platform Div.,
    CM Plus Corp.


    Shinichi Kodato
    Senior Manager,
    Business Development Div.,
    Mitsui-Soko Holdings Co., Ltd.

    Diversifying Pharmaceutical Products Development -Challenges with Drug Delivery Systems-


    Kazuhito Yamada
    General Manager,
    Advanced Technology Operations,
    Global Pharmaceutical Technology Development,
    Santen Pharmaceutical Co., Ltd.


    Kageshi Maruyama
    Senior Vice President,
    Corporate Business Development Div.,
    Nitto Denko Corp.


    Kazuhiko Ishihara
    Professor,
    Dept. of Materials Engineering,
    The University of Tokyo

    June
    30

    [Thu]
    9:30
    |
    12:30
    IPJ-2 Bilingual (English/Japanese)
    for Details
    IPJ-7 Bilingual (English/Japanese)
    for Details

    Latest Trends in Continuous Manufacturing Technology - New Streams -


    Yasuhiro Suzuki
    Senior Researcher,
    Solid Formulation Research Group 1,
    Formulation Technology Research Labs.,
    Pharmaceutical Technology Div.,
    Daiichi Sankyo Co., Ltd.


    Masaru Konishi
    Manager,
    Market Development Group,
    Pharmaceuticals Sales Dept., Sales Div.1,
    Yokogawa Solution Service Corp.


    Koichiro Kase
    Director,
    Regulatory Affairs,
    CMC Sciences,
    Janssen Pharmaceutical K.K.

    Pharmaceutical Industry's Inroads into Asia, Success Cases and Challenges to Overcome


    Norio Kaneko
    Chairman,
    Eisai China Holdings Ltd.


    Ping Xu
    Board Director,
    EPS Ekishin Co., Ltd.


    John Duggan
    Director of Life Sciences, Asia,
    Management,
    PM Group

    June
    30

    [Thu]
    15:00
    |
    18:00
    IPJ-3

    Japanese Only

    for Details
    IPJ-8 Bilingual (English/Japanese)
    for Details

    What is the New Wave of ICH-Q Guidelines? -From Drug Substances to Drug Products-


    Tomonori Nakagawa
    Manager,
    Quality Control Dept.,
    Production Headquarters,
    Otsuka Pharmaceutical Co., Ltd.


    Masaaki Wada
    Senior Director,
    Head of Analytical Chemistry Dept.,
    Analytical R&D Center,
    CMC R&D Div.,
    Shionogi & Co., Ltd.


    Yasuyoshi Agata
    Analytical Science 2,
    Analytical Research Labs.,
    Technology,
    Astellas Pharma Inc.

    Takuro Sasayama
    Researcher,
    Quality Development Dept.,
    Process Analysis and Evaluation 1G,
    Chugai Pharma Manufacturing Co., Ltd.

    Increasingly Growing Roles of CDMOs - Considering Japan's Pharmaceutical Manufacture That Stands at a Major Juncture -


    Kenichi Murata
    Representative Director,
    K.M.Consulting, Inc.


    Takeshi Mitani
    Representative Director,
    Cmic CMO Co., Ltd.


    Anil Kane
    Executive Director,
    Global Head of Formulations,
    Pharmaceutical Development Services,
    Patheon Inc.

    July
    1
    [Fri]
    9:30
    |
    12:30
    IPJ-4

    Japanese Only

    for Details
    IPJ-9 Bilingual (English/Japanese)
    for Details

    Latest Trends in Containment Technology and Actual Examples


    Yuta Miyazaki
    Late Stage Oral Formulation R&D,
    Pharmaceutical R&D,
    CMC & Production HQs,
    Ono Pharmaceutical Co., Ltd.


    Kenichi Ashihara
    Research Fellow,
    Oral Formulation Development,
    Pharmaceutical Research and Technology Labs.,
    Technology,
    Astellas Pharma Inc.


    Morihiko Takeda
    President,
    Pharma Solutions Co., Ltd.

    Challenges and Advances in Biopharmaceutical Manufacturing Technology


    Seiji Saito
    Leader,
    Production Engineering Dept.,
    Pharmaceutical Technology Div.,
    Chugai Pharmaceutical Co., Ltd.


    Atsushi Ogawa
    Director, Vice President,
    Project Management,
    General Manager Manufacturing Development Div.,
    Unigen Inc.


    TH Kim
    President & CEO,
    Samsung BioLogics

    July
    1
    [Fri]
    15:00
    |
    18:00
    IPJ-5

    Japanese Only

    for Details
    IPJ-10

    Japanese Only

    for Details

    Latest Pharmaceutical Factory Examples


    Yoshitaka Tsuchida
    General Manager,
    Industrial Technology Dept.,
    Toyama Chemical Co., Ltd.


    Toshiaki Sasaki
    Senior Director,
    CMO Business Development,
    Cmic Holdings Co., Ltd.


    Shinya Kumagai
    Professional Engineer, Chief Engineer(Hydrometallurgy),
    No.3 Business Div.,
    JGC Corp.

    Latest Challenges and Trends in Pharmaceutical Products Packaging


    Hitoshi Kuzuu
    President,
    MicroTechnica Co., Ltd.

    Osamu Ishihara
    Site Manager,
    Shizuoka Site,
    AY Pharmaceuticals Co., Ltd.

    Hiroaki Kuwano
    Manager,
    Japan Packaging Shared Service Production Div.,
    GlaxoSmithKline K.K.

  • Special Session

    Free / Pre-registration required
    IPJ-S
    June 29th[Wed]13:00-14:40

    Japanese Only

    for Details
    Prospects and Efforts toward "Regenerative Medicine" that Opens the Way for the Pharmaceutical Industry

    Experience and Current Issues of the Regenerative Medicine Product

    鮫島 正

    Tadashi Sameshima
    General Manager,
    Terumo Corp.

    JCR Pharmaceuticals' Challenges to Drug Development -Commercialization of Japan's First Allogeneic Cell-based Regenerative Product-

    西野 勝哉

    Katsuya Nishino
    Representative Director, Executive Vice President,
    JCR Pharmaceuticals Co., Ltd.

    Efforts toward Industrialization of Regenerative Medicine in Keeping with Law Enactment

    西村 秀隆

    Hidetaka Nishimura
    Director,
    Bio-Industry Div.,
    Ministry of Economy, Trade, and Industry




  • (Honorifics omitted) Please note that recording and photography is strictly prohibited. Speakers and programs are subject to change. Textbooks of some presentations might not be available.